舒泰神(300204.SZ)拟定增股票募资不超12.53亿元
Staidson BioPharmStaidson BioPharm(SZ:300204) 智通财经网·2025-09-09 09:13

Group 1 - The core point of the article is that Shutaishen (300204.SZ) has announced a plan to issue shares to specific investors in 2025, aiming to raise a total of no more than RMB 1.253 billion [1] - The total amount raised will be allocated as follows: RMB 883 million for innovative drug research and development projects [1] - RMB 370 million will be used to supplement working capital [1]